Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies. J of Skin. 2021;5(6):s51. doi:10.25251/skin.5.supp.51